Sign up to save your podcasts
Or
Share Can AAV continue to deliver the promise of gene therapy?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Can AAV continue to deliver the promise of gene therapy?
In this episode, Charlotte Barker, Editor, BioInsights, will be discussing the future of AAV-based gene therapy manufacturing with Elie Hanania, VP of Process Development Viral Vector Technologies at Avid Bioservices, and Ratish Krishnan, Senior Strategy Consultant at Merck Life Sciences.
View all episodes
By BioInsightsIn this episode, Charlotte Barker, Editor, BioInsights, will be discussing the future of AAV-based gene therapy manufacturing with Elie Hanania, VP of Process Development Viral Vector Technologies at Avid Bioservices, and Ratish Krishnan, Senior Strategy Consultant at Merck Life Sciences.